Clinical Trial

Ketorolac on Posterior Thoracolumbar Spinal Fusions

Study Description

Ketorolac on Posterior Thoracolumbar Spinal Fusions

To determine is low-dose ketorolac use in the early post-operative period (within 48 hours) provides adequate analgesia without long term adverse effect on spinal fusion rates when compared to post-operative analgesia without the use of NSAIDs.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - Saline

1 ml saline IV Q6H

Drug - Ketorolac

15 mg (15 mg/ml) IV Q6H

Additional Information

Official Study Title

The Effect of Ketorolac on Posterior Thoracolumbar Spinal Fusions: a Prospective Randomized Controlled Trial

Clinical Trial ID

NCT03278691

ParticipAid ID

Qe1Z3a